… The partial effect of anti-angiogenic regimens in human cancers and the wide range of …
However, the results of randomized phase II study in NSCLC cancer patients selected for …

… versus capecitabine as a treatment for advanced breast cancer patients with disease recurrence
… PDGF family plays a key role in a wide range of oncologic activities essential for cancer …

… switch in the early steps of tumor progression as well as in the micrometastasis awakening
… tumor angiogenesis and the potential of the use of dietary derived inhibitors of angiogenesis …

… These proinflammatory adipokines initiate a cascade of changes that result in broader …
alter the tumor microenvironment and promote angiogenesis and cancer cell proliferation. For …

… The aim of this paper was to review the evidence for anti-angiogenic therapy in cancer
therapeutics and the mechanisms and management of tumour resistance to antiangiogenic …

… most broadly interrogated targets … treatment has shown promising anti-tumor activity,
especially in solid tumors (117). Ang2-VEGF CrossMab is another therapy targeting angiogenesis …

… to target angiogenesis in cancer patients is based on the blocking of the main pro-angiogenic …
S100 proteins have a broad range of intracellular and extracellular functions, including the …

… drugs and the combination therapy to figure out how to improve the therapeutic efficacy.
Here, we broadly summarize various signaling pathways in tumor angiogenesis and discuss the …

… cancer patients. This review will focus on the role of anti-angiogenesis strategies in cancer
treatment… pursuing the development of broad-spectrum anti-angiogenesis compounds, which …

… in the understanding of the rationale for targeting angiogenesis and recently investigated
substances with … Broad targeting of angiogenesis for cancer prevention and therapy. Semin …